YBX1 and nonpapillary renal cell carcinoma: Also, we detected a higher level of LYAR, YBX1, PNRC1, RNF115, and TCF25 on papRCC CD8+ T cells compared with that on ccRCC CD8+ T cells (Figure 4B), while MYL12B and LINC01420 antibodies were not available.